| Year |
Citation |
Score |
| 2021 |
Jahangiri P, Dreyfuss AD, Duan F, Snyder BS, Borja AJ, Pournazari K, Kothekar E, Arani L, Al-Zaghal A, Seraj SM, Hancin EC, Pinheiro B, Werner TJ, Swisher-McClure S, Feigenberg SJ, et al. Implementation of FDG-PET/CT imaging methodology for quantification of inflammatory response in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial. American Journal of Nuclear Medicine and Molecular Imaging. 11: 415-427. PMID 34754612 |
0.33 |
|
| 2020 |
Billatos E, Ash SY, Duan F, Xu K, Romanoff J, Marques H, Moses E, Han MK, Regan EA, Bowler RP, Mason SE, Doyle TJ, San José Estépar R, Rosas IO, Ross JC, et al. Distinguishing smoking related lung disease phenotypes via imaging and molecular features. Chest. PMID 32946850 DOI: 10.1016/J.Chest.2020.08.2115 |
0.316 |
|
| 2019 |
Billatos E, Duan F, Moses E, Marques H, Mahon I, Dymond L, Apgar C, Aberle D, Washko G, Spira A. Detection of early lung cancer among military personnel (DECAMP) consortium: study protocols. Bmc Pulmonary Medicine. 19: 59. PMID 30845938 DOI: 10.1186/S12890-019-0825-7 |
0.421 |
|
| 2019 |
Lowe VJ, Duan F, Subramaniam RM, Sicks JD, Romanoff J, Bartel T, Yu JQM, Nussenbaum B, Richmon J, Arnold CD, Cognetti D, Stack BC. Multicenter Trial of [F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801182. PMID 30768363 DOI: 10.1200/Jco.18.01182 |
0.345 |
|
| 2019 |
Kyriakopoulos C, Chen Y, Duan F, Jeraj R, Luo J, Antonarakis ES, Liu G, Carducci MA. Cabazitaxel with abiraterone versus abiraterone alone randomized trial for extensive disease following docetaxel: the CHAARTED 2 Trial: A trial of the ECOG-ACRIN Cancer Research Group (EA8153). Journal of Clinical Oncology. 37: TPS5094-TPS5094. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps5094 |
0.316 |
|
| 2019 |
Hijazi K, Lel J, Billatos E, Moses E, Stevenson CS, Lorenzi MV, Liu G, Campbell JD, Koga Y, Zhang J, Duan F, Marques H, Lenburg ME, Spira AE, Beane J. Abstract 3393: Altered immune response in the transcriptome of patients with lung cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3393 |
0.351 |
|
| 2019 |
Peikert T, Duan F, Rajagopalan S, Karwoski R, Balar A, Lakhani D, Antic S, Bartholmai B, Tucker J, Massion P, Maldonado F. OA06.06 Independent Validation of a Novel High-Resolution Computed Tomography-Based Radiomic Classifier for Indeterminate Lung Nodules Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.439 |
0.35 |
|
| 2018 |
Peikert T, Duan F, Rajagopalan S, Karwoski RA, Clay R, Robb RA, Qin Z, Sicks J, Bartholmai BJ, Maldonado F. Correction: Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial. Plos One. 13: e0205311. PMID 30278080 DOI: 10.1371/Journal.Pone.0205311 |
0.355 |
|
| 2018 |
Andriole GL, Kostakoglu L, Chau A, Duan F, Mahmood U, Mankoff DA, Schuster DM, Siegel BA. The Impact of Positron Emission Tomography with F-Fluciclovine on the Management of Patients with Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial. The Journal of Urology. PMID 30179618 DOI: 10.1016/J.Juro.2018.08.050 |
0.365 |
|
| 2018 |
Peikert T, Duan F, Rajagopalan S, Karwoski RA, Clay R, Robb RA, Qin Z, Sicks J, Bartholmai BJ, Maldonado F. Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial. Plos One. 13: e0196910. PMID 29758038 DOI: 10.1371/Journal.Pone.0196910 |
0.361 |
|
| 2017 |
Gareen IF, Hillner BE, Hanna L, Makineni R, Duan F, Shields AF, Subramaniam RM, Siegel B. Hospice Admission and Survival following 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29284672 DOI: 10.2967/Jnumed.117.205120 |
0.421 |
|
| 2017 |
Hillner BE, Hanna L, Makineni R, Duan F, Shields AF, Subramaniam RM, Gareen I, Siegel BA. Intended vs. Inferred Treatment after 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29191854 DOI: 10.2967/Jnumed.117.205047 |
0.395 |
|
| 2017 |
Salavati A, Duan F, Snyder BS, Wei B, Houshmand S, Khiewvan B, Opanowski A, Simone CB, Siegel BA, Machtay M, Alavi A. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28689281 DOI: 10.1007/S00259-017-3753-X |
0.419 |
|
| 2017 |
Hopkins RJ, Duan F, Chiles C, Greco EM, Gamble GD, Aberle D, Young RP. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk: Results from the NLST-ACRIN Cohort (N=18, 714). Annals of the American Thoracic Society. PMID 28076701 DOI: 10.1513/Annalsats.201609-741Oc |
0.366 |
|
| 2017 |
Gierada DS, Pinsky PF, Duan F, Garg K, Hart EM, Kazerooni EA, Nath H, Watts JR, Aberle DR. Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants. European Radiology. PMID 28050695 DOI: 10.1007/S00330-016-4705-8 |
0.399 |
|
| 2017 |
Stack BC, Duan F, Sicks J, Romanoff J, Opanowski A, Horng D, Mahon I, Hollenbeak CS. The negative predictive value (NPV) of FDG-PET/CT in the Head and Neck Squamous Cell Carcinoma (HNSCC) N0 patient, the first report of the ACRIN 6685 trial. Journal of Clinical Oncology. 35: 6041-6041. DOI: 10.1200/Jco.2017.35.15_Suppl.6041 |
0.312 |
|
| 2017 |
Young RP, Hopkins RJ, Duan F, Greco E, Chiles C, Aberle D, Gamble G. Stratification of NLST-ACRIN screening participants identifies the “sweet spot” of screening by identifying early stage lung cancers most amenable to curative surgery (N=10,054) Respiratory Medicine. 132: 280. DOI: 10.1016/J.Rmed.2017.07.055 |
0.356 |
|
| 2017 |
Hopkins RJ, Young RP, Duan F, Greco E, Chiles C, Aberle D, Gamble G. Lung cancer screening and the effects of competing causes of death in the ACRIN-NLST sub-study Respiratory Medicine. 132: 279-280. DOI: 10.1016/J.Rmed.2017.07.054 |
0.368 |
|
| 2017 |
Hopkins RJ, Young RP, Duan F, Greco E, Chiles C, Aberle D, Gamble G. Chromosome 15q25 locus and genetic susceptibility to lung cancer, COPD, and smoking: Triple whammy effect in the ACRIN-NLST cohort sub-study (N=10,054) Respiratory Medicine. 132: 279. DOI: 10.1016/J.Rmed.2017.07.053 |
0.309 |
|
| 2017 |
Hopkins R, Duan F, Greco E, Chiles C, Gamble G, Aberle D, Young R. OA 06.06 Chr15q25 Locus Confers Risk of Lung Cancer, COPD and Smoking: Triple Whammy Effect in the ACRIN NLST Sub-Study (N=9,270) Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2017.09.358 |
0.331 |
|
| 2017 |
Peikert T, Duan F, Rajagopalan S, Karwoski R, Qin Z, Sicks J, Clay R, Robb R, Bartholmai B, Maldonado F. P2.13-014 Computed Tomography-Based Radiomic Classifier Distinguishes Malignant from Benign Pulmonary Nodules in the National Lung Screening Trial Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2017.09.1361 |
0.377 |
|
| 2016 |
Bazan JG, Duan F, Snyder BS, Horng D, Graves EE, Siegel BA, Machtay M, Loo BW. Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27645692 DOI: 10.1007/S00259-016-3520-4 |
0.349 |
|
| 2016 |
Subramaniam RM, Shields AF, Sachedina A, Hanna L, Duan F, Siegel BA, Hillner BE. Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry. The Oncologist. PMID 27401896 DOI: 10.1634/Theoncologist.2015-0364 |
0.379 |
|
| 2016 |
McComb BL, Munden RF, Duan F, Jain AA, Tuite C, Chiles C. Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial. Clinical Imaging. 40: 936-943. PMID 27203287 DOI: 10.1016/J.Clinimag.2016.04.013 |
0.338 |
|
| 2016 |
Ohri N, Duan F, Snyder BS, Wei B, Machtay M, Alavi A, Siegel BA, Johnson DW, Bradley JD, DeNittis A, Werner-Wasik M, El Naqa I. Pretreatment 18FDG-PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912429 DOI: 10.2967/Jnumed.115.166934 |
0.382 |
|
| 2015 |
Hopkins RJ, Duan F, Young RP. Lung Cancer Susceptibility, Ethnicity, and the Benefits of Computed Tomography Screening. American Journal of Respiratory and Critical Care Medicine. 192: 1394-6. PMID 26623689 DOI: 10.1164/Rccm.201507-1469Le |
0.41 |
|
| 2015 |
Markovina S, Duan F, Snyder BS, Siegel BA, Machtay M, Bradley JD. Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235. International Journal of Radiation Oncology, Biology, Physics. 93: 597-605. PMID 26461002 DOI: 10.1016/J.Ijrobp.2015.04.026 |
0.391 |
|
| 2015 |
Kostakoglu L, Duan F, Idowu MO, Jolles PR, Bear HD, Muzi M, Cormack J, Muzi JP, Pryma DA, Specht JM, Hovanessian-Larsen L, Miliziano J, Mallett S, Shields AF, Mankoff DA, et al. A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1681-9. PMID 26359256 DOI: 10.2967/Jnumed.115.160663 |
0.351 |
|
| 2015 |
Young RP, Duan F, Chiles C, Hopkins RJ, Gamble GD, Greco EM, Gatsonis C, Aberle D. Airflow Limitation and Histology-shift in the National Lung Screening Trial: the NLST-ACRIN Cohort Substudy (N=18, 714). American Journal of Respiratory and Critical Care Medicine. PMID 26199983 DOI: 10.1164/Rccm.201505-0894Oc |
0.414 |
|
| 2015 |
Maldonado F, Duan F, Raghunath SM, Rajagopalan S, Karwoski RA, Garg K, Greco E, Nath H, Robb RA, Bartholmai BJ, Peikert T. Noninvasive CT-Based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial. American Journal of Respiratory and Critical Care Medicine. PMID 26052977 DOI: 10.1164/Rccm.201503-0443Oc |
0.425 |
|
| 2015 |
Chiles C, Duan F, Gladish GW, Ravenel JG, Baginski SG, Snyder BS, DeMello S, Desjardins SS, Munden RF. Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods. Radiology. 276: 82-90. PMID 25759972 DOI: 10.1148/Radiol.15142062 |
0.326 |
|
| 2015 |
Ohri N, Duan F, Machtay M, Gorelick JJ, Snyder BS, Alavi A, Siegel BA, Johnson DW, Bradley JD, DeNittis A, Werner-Wasik M. Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235. Journal of the National Cancer Institute. 107. PMID 25688115 DOI: 10.1093/Jnci/Djv004 |
0.41 |
|
| 2015 |
Yu EY, Duan F, Muzi M, Deng X, Chin BB, Alumkal JJ, Taplin ME, Taub JM, Herman B, Higano CS, Doot RK, Hartfeil D, Febbo PG, Mankoff DA. Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 354-60. PMID 25635138 DOI: 10.2967/Jnumed.114.146936 |
0.308 |
|
| 2015 |
Hillner BE, Siegel BA, Hanna L, Duan F, Quinn B, Shields AF. 18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 222-8. PMID 25593113 DOI: 10.2967/Jnumed.114.150391 |
0.386 |
|
| 2014 |
Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. Journal of the National Cancer Institute. 106. PMID 25326638 DOI: 10.1093/Jnci/Dju284 |
0.415 |
|
| 2014 |
Gareen IF, Duan F, Greco EM, Snyder BS, Boiselle PM, Park ER, Fryback D, Gatsonis C. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer. 120: 3401-9. PMID 25065710 DOI: 10.1002/Cncr.28833 |
0.377 |
|
| 2014 |
Hillner BE, Siegel BA, Hanna L, Duan F, Shields AF, Quinn B, Coleman RE. Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1054-61. PMID 24819422 DOI: 10.2967/Jnumed.113.135475 |
0.4 |
|
| 2014 |
Hillner BE, Siegel BA, Hanna L, Duan F, Shields AF, Coleman RE. Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 574-81. PMID 24578240 DOI: 10.2967/Jnumed.113.130005 |
0.37 |
|
| 2014 |
Jiwani A, Maple E, Schnall M, Mahon I, Apgar C, Browning R, More K, Morris M, Parrish J, Atwood C, Battaile J, Garshick E, Gatsonis C, Goldstein R, Kieth R, ... ... Duan F, et al. Detection and Validation of Molecular Biomarkers for the Early Detection of Lung Cancer Among Military and Veteran Populations: The DECAMP Consortium Chest. 146: 590A. DOI: 10.1378/Chest.1993874 |
0.34 |
|
| 2014 |
Kostakoglu L, Duan F, Idowu MO, Jolles PR, Bear HD, Muzi M, Cormack J, Pryma DA, Specht JM, Hovanessian Larsen L, Miliziano J, Mallett S, Shields AF, Mankoff DA. Phase II study of 3'-deoxy-3'-18F fluorothymidine PET/CT (FLT-PET) in the assessment of early response in locally advanced breast cancer (LABC): Preliminary results of ACRIN 6688. Journal of Clinical Oncology. 32: 526-526. DOI: 10.1200/Jco.2014.32.15_Suppl.526 |
0.356 |
|
| 2014 |
Ohri N, Duan F, Machtay M, Gorelick JJ, Snyder BS, Alavi A, Siegel B, Johnson DW, Bradley JD, DeNittis AS, Werner-Wasik M. Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668/RTOG 0235 : Locally Advanced Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.166 |
0.422 |
|
| 2014 |
Bazan J, Duan F, Snyder B, Horng D, Graves E, Siegel B, Machtay M, Loo B. Metabolic Tumor Volume Predicts Overall Survival in Patients With Stage III Non-Small Cell Lung Cancer Treated on ACRIN 6668/RTOG 0235 International Journal of Radiation Oncology*Biology*Physics. 90: S3-S4. DOI: 10.1016/J.Ijrobp.2014.08.027 |
0.371 |
|
| 2014 |
Ohri N, Duan F, Machtay M, Gorelick JJ, Snyder BS, Alavi A, Siegel B, Johnson DW, Bradley JD, DeNittis AS, Werner-Wasik M. Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668/RTOG 0235 International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.612 |
0.409 |
|
| 2014 |
Markovina S, Duan F, Snyder B, Siegel B, Machtay M, Bradley J. Residual Post-Treatment FDG Avidity in Regional Lymph Nodes Impacts Local-Regional Control in Patients Receiving Definitive Chemoradiation for Non-small Cell Lung Cancer: A Secondary Analysis of ACRIN 6668/RTOG 0235 International Journal of Radiation Oncology*Biology*Physics. 90: S144. DOI: 10.1016/J.Ijrobp.2014.05.611 |
0.327 |
|
| 2013 |
Machtay M, Duan F, Siegel BA, Snyder BS, Gorelick JJ, Reddin JS, Munden R, Johnson DW, Wilf LH, DeNittis A, Sherwin N, Cho KH, Kim SK, Videtic G, Neumann DR, et al. Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3823-30. PMID 24043740 DOI: 10.1200/Jco.2012.47.5947 |
0.402 |
|
| 2013 |
Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, et al. Results of the two incidence screenings in the National Lung Screening Trial. The New England Journal of Medicine. 369: 920-31. PMID 24004119 DOI: 10.1056/Nejmoa1208962 |
0.353 |
|
| 2013 |
Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, et al. Results of initial low-dose computed tomographic screening for lung cancer. The New England Journal of Medicine. 368: 1980-91. PMID 23697514 DOI: 10.1056/Nejmoa1209120 |
0.41 |
|
| 2013 |
Park ER, Gareen IF, Jain A, Ostroff JS, Duan F, Sicks JD, Rakowski W, Diefenbach M, Rigotti NA. Examining whether lung screening changes risk perceptions: National Lung Screening Trial participants at 1-year follow-up. Cancer. 119: 1306-13. PMID 23280348 DOI: 10.1002/Cncr.27925 |
0.357 |
|
| 2013 |
Yu EY, Duan F, Muzi M, Gorelick J, Chin B, Alumkal JJ, Taplin M, Herman B, Higano CS, Doot RK, Hartfeil DM, Febbo PG, Mankoff DA. Correlation of 18F-fluoride PET response to dasatinib in castration-resistant prostate cancer bone metastases with progression-free survival: Preliminary results from ACRIN 6687. Journal of Clinical Oncology. 31: 5003-5003. DOI: 10.1200/Jco.2013.31.15_Suppl.5003 |
0.332 |
|
| 2012 |
Hillner BE, Siegel BA, Hanna L, Shields AF, Duan F, Gareen IF, Quinn B, Coleman RE. Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 831-7. PMID 22448033 DOI: 10.2967/Jnumed.112.103911 |
0.408 |
|
| 2011 |
Jolles PR, Kostakoglu L, Bear HD, Idowu MO, Kurdziel KA, Shankar L, Mankoff DA, Duan F, L'Heureux D. ACRIN 6688 phase II study of fluorine-18 3'-deoxy-3' fluorothymidine (FLT) in invasive breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: TPS125. PMID 28022932 DOI: 10.1200/Jco.2011.29.15_Suppl.Tps125 |
0.342 |
|
| 2011 |
Hillner BE, Siegel BA, Shields AF, Duan F, Gareen IF, Hanna L, Coleman RE. Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 161-5. PMID 21080232 DOI: 10.1007/S11307-010-0427-5 |
0.315 |
|
| 2011 |
Jolles P, Kostakoglu L, Bear H, Idowu M, Kurdziel K, Shankar L, Mankoff D, Duan F, L'Heureux D. OT2-05-03: ACRIN 6688 Phase II Study of Fluorine-18 3′-Deoxy-3′ Fluorothymidine (FLT) in Invasive Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Ot2-05-03 |
0.365 |
|
| 2011 |
Machtay M, Duan F, Snyder B, Gorelick J, DeNittis AS, Chiles C, Mahon I, Alavi A, Siegel BA, Bradley JD. Can Tumor FDG-PET Scan Uptake (SUV) Predict Local Control in Stage III NSCLC? Preliminary Results from ACRIN 6668/RTOG 0235 International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.277 |
0.337 |
|
| 2010 |
Patz EF, Caporaso NE, Dubinett SM, Massion PP, Hirsch FR, Minna JD, Gatsonis C, Duan F, Adams A, Apgar C, Medina RM, Aberle DR. National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1502-6. PMID 20871260 DOI: 10.1097/Jto.0B013E3181F1C634 |
0.44 |
|
| 2010 |
Franklin WA, Berg CD, Tze S, Groshong S, Achcar RD, Duan F, Adams A, Marquez G, Seligson DB, Aberle DR, Acrin. Tissue sampling and digital histologic imaging for the National Lung Screening Trial. Journal of Clinical Oncology. 28. DOI: 10.1200/Jco.2010.28.15_Suppl.E12032 |
0.331 |
|
| Show low-probability matches. |